A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Four-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Trial Profile

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Four-Part Evaluation of the Efficacy and Safety of Locally Administered HTX-011 for Postoperative Analgesia Following Bunionectomy

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Bupivacaine/meloxicam (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms HTX-011
  • Sponsors Heron Therapeutics
  • Most Recent Events

    • 23 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Sep 2015 Results published in Heron Therapeutics media release.
    • 22 Sep 2015 Primary endpoint has been met. (SPI0-24), as per Heron Therapeutics media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top